We are live on
!
Find out more
CAG
Crestwood Advisors Group Portfolio holdings
AUM
$5.94B
1-Year Est. Return
18.44%
This Fund
S&P 500
This Quarter
Est. Return
-2.88%
1 Year Est. Return
+18.44%
3 Year Est. Return
+65.91%
5 Year Est. Return
+80.01%
10 Year Est. Return
+299.27%
AUM
$5.26B
AUM Growth
-$72.9M
(-1.4%)
Cap. Flow
+$148M
Cap. Flow
% of AUM
2.8%
Top 10 Holdings %
Top 10 Hldgs %
29.45%
Holding
516
New
57
Increased
243
Reduced
170
Closed
18
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Small & Mid Cap Enhanced Equity ETF
JMEE
|
+$67.9M |
| 2 |
AstraZeneca
AZN
|
+$30.9M |
| 3 |
Invesco S&P MidCap Quality ETF
XMHQ
|
+$29M |
| 4 |
NVIDIA
NVDA
|
+$20.3M |
| 5 |
Diageo
DEO
|
+$18.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$33.2M |
| 2 |
State Street SPDR Portfolio S&P 600 Small Cap ETF
SPSM
|
+$25.6M |
| 3 |
Stryker
SYK
|
+$15.9M |
| 4 |
AllianceBernstein
AB
|
+$9.85M |
| 5 |
Qualcomm
QCOM
|
+$8.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.45% |
| 2 | Financials | 14.34% |
| 3 | Consumer Discretionary | 9.44% |
| 4 | Healthcare | 8.72% |
| 5 | Communication Services | 6.03% |
Similar funds
AL
CGPCS
BP
BTCPP
WAM
GFM
VAM
TCM
Crestwood Advisors Group's Q1 2025 Portfolio in Review
As of Q1 2025, Crestwood Advisors Group held 516 positions worth $5.26B, down 1.4% from $5.34B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Crestwood Advisors Group's Q1 2025 filing shows 57 new, 243 increased, 170 reduced and 18 closed positions. Its largest new stake was JPMorgan Small & Mid Cap Enhanced Equity ETF: 1,136,446 shares worth $63.6M. The largest sale was Fortive, an estimated $33.2M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 28% a quarter earlier, followed by Financials and Consumer Discretionary.
- Crestwood Advisors Group's largest Q1 2025 buy was JPMorgan Small & Mid Cap Enhanced Equity ETF: 1,136,446 shares worth $63.6M.
- Crestwood Advisors Group added most to AstraZeneca in Q1 2025, an estimated $30.9M increase.
- Crestwood Advisors Group's biggest Q1 2025 reduction was Fortive, cutting an estimated $33.2M.
- Crestwood Advisors Group fully exited Emcor in Q1 2025, selling an estimated $831K.
- Crestwood Advisors Group's ten largest holdings make up 29% of its $5.26B portfolio in Q1 2025.
- Crestwood Advisors Group opened 57 new positions and closed 18 in Q1 2025.
- Crestwood Advisors Group's portfolio value fell 1.4% quarter-over-quarter to $5.26B.
Based on Crestwood Advisors Group's 13F filing for Q1 2025, filed 5 May 2025.